EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma

Soyean Kwon, Hye Yeon Park, Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06372-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Soyean Kwon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Mobilization, Antineoplastic Combined Chemotherapy Protocols, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autologous stem cell transplantation (ASCT) is integral to treating newly diagnosed multiple myeloma (MM). While novel therapies improve response rates, they also hinder stem cell mobilization. This study evaluates the impacts of induction regimens on mobilization, collection, and ASCT outcomes. We analyzed 228 patients divided into three groups: bortezomib-thalidomide-dexamethasone (VTD, N = 117); bortezomib-lenalidomide-dexamethasone (VRD, N = 57); and daratumumab-VTD (DVTD, N = 54). Baseline characteristics showed no significant differences among the groups. Chemo-mobilization was most common in VTD (20.5%) compared to VRD (12.3%) and DVTD (5.6%). Total CD34 + cell yield (x10⁶/kg) was highest in VTD (7.1 ± 3.5) compared to VRD (5.8 ± 3.2) and DVTD (5.4 ± 2.4) [ p = 0.0001]. Second mobilization was required most frequently in VRD (40.4%) compared to DVTD (24.1%) and VTD (16.2%) [ p = 0.0010]. Plerixafor use was highest in VRD (40.4%) compared to DVTD (24.1%) and VTD (12.0%) [ p = 0.0001]. Mobilization duration was longest in VRD (4.0 ± 1.9 days) and shortest in VTD (3.2 ± 1.7 days) [ p = 0.0038]. Infused CD34 cells and platelet engraftment times were comparable among groups. Neutrophil engraftment was delayed in VRD (12.1 ± 0.9 days) compared to DVTD (11.8 ± 1.2) and VTD (11.6 ± 0.7) [ p = 0.0014]. Prompt stem cell collection is essential in lenalidomide regimens to minimize mobilization challenges. While DVTD demonstrated comparable mobilization efficiency, it produced fewer CD34 cells than VTD, indicating potential challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationInduction ChemotherapyHumansMiddle AgedMaleFemaleAgedDexamethasoneLenalidomideThalidomideBortezomibAdultTransplantation, AutologousAntibodies, MonoclonalRetrospective StudiesAntigens, CD34

Stichwörter der Autor:innen

Autologous stem cell transplantation (ASCT)CD34 + cell yieldDaratumumab-VTD (DVTD)Induction regimensMultiple myeloma (MM)Stem cell mobilization

Substanzen

DexamethasoneLenalidomideThalidomideBortezomibdaratumumabAntibodies, MonoclonalAntigens, CD34

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
  • Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. jaminbyun@snu.ac.kr.

Förderung

  • Seoul National University Hospital

Zitieren

APA

Kwon, S., Park, H. Y., Byun, J. M., Shin, D. Y., Koh, Y., Hong, J., Kim, I., & Yoon, S. S. (2025). Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma. Annals of Hematology. https://doi.org/10.1007/s00277-025-06372-4

Vancouver

Kwon S, Park HY, Byun JM, Shin DY, Koh Y, Hong J, et al. Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma. Annals of Hematology. 2025. doi:10.1007/s00277-025-06372-4

BibTeX
@article{Kwon2025,
  author = {Kwon, Soyean and Park, Hye Yeon and Byun, Ja Min and Shin, Dong-Yeop and Koh, Youngil and Hong, Junshik and Kim, Inho and Yoon, Sung-Soo},
  title = {Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06372-4}
}
Kostenlos starten →